WAPNICK PAMELA (Chief Financial Officer) sold 2.2% of their position (1.58K shares) of METAGENOMI THERAPEUTICS, INC. on the open market
Open‑market sale worth $2.9K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 12/1/2025ACC: 0001193125-25-304218
Officer· Chief Financial Officer
Since Mar 2026
+118.42K
Net shares
Net buyer
$2.9K
Total sold
1
Open market trades
0B · 1S
2
Total transactions
120K acquired · 1.58K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−1.58K
Price / share
$1.81
Trade value
$2.85K
% of position
2.2%
9/5/2025
72.11K→70.53K
Common Stock
Direct
Shares
+120K
Price / share
$1.60
Trade value
$192K
% of position
170.1%
12/1/2025
70.53K→190.53K
Total
Net shares
+118.42K
Net value
$189.15K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/5/2025 | S · Sale | −1.58K | $1.81 | $2.85K | 2.2% | 72.11K | 70.53K |
| Common Stock Direct | 12/1/2025 | A · Award | +120K | $1.60 | $192K | 170.1% | 70.53K | 190.53K |
| Total | +118.42K | $189.15K | ||||||
Derivative Transactions0
No derivative transactions reported